Clinical Trials
120 trialsSCOUT-1
AstraZeneca
BIOC
KU Leuven
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
LONGEVITI
University of Alberta
iCaRe2
University of Nebraska
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
University of Wisconsin, Madison
REFLECT
University Health Network, Toronto
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
OLIVIA
AstraZeneca
GYNECO-IMM&CO
Centre Leon Berard
PROBE-II
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CER
Cancer Support Community, Research and Training Institute, Philadelphia
EPOCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ECHO
Mayo Clinic
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
University of Washington
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
National Health Research Institutes, Taiwan
SENTRY
University of Utah
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
PROVE
Catholic University of the Sacred Heart
THRIVE
WellSpan Health
HERO
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Carevive Systems, Inc.
PARIB-OLD-PRO²
Hospices Civils de Lyon
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
M.D. Anderson Cancer Center
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
University Hospital Tuebingen
Healthy Volunteers Study
Abramson Cancer Center at Penn Medicine
Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
SMARAGD
iOMEDICO AG
EXoPERT EMERALD Clinical Study
EXoPERT
CAMPERR
Adela, Inc
SCORE
Natera, Inc.
CCANED-CIPHER
Dysplasia Diagnostics Limited
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
University of Southern California
LIBERATE
University Health Network, Toronto
Clinical Pre-screening Protocol for Ovarian Cancer
Allarity Therapeutics
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
The Better, Harder, Faster, Stronger Study
Wake Forest University Health Sciences
DOvEEgene Fleur: New Uterine Sampling Tool
McGill University
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Massachusetts General Hospital
GEN_EXP_CO2021
Azienda USL Reggio Emilia - IRCCS
DETECT
University of Alabama at Birmingham
RWS-MTB
Sun Yat-sen University
INFPELV
Complejo Hospitalario Universitario Insular Materno Infantil
UNTOLD Ovarian Cancer Unmet Needs Survey
Masonic Cancer Center, University of Minnesota